Taking people in GermanyPhase 1
Tests COR-1389 safety in healthy adults aged 18 to 64
Tests COR-1389 in healthy adults, checking its safety and how the body processes it.
Key facts
- Who runs it
- Corteria Pharmaceuticals
- Where
- Neuss, GermanySee the site
- Trial code
- Registry title
- A STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF COR-1389
- Status
- Recruiting
- Phase
- Phase 1
- People taking part
- 140 people, planned
- Started
- 10 Sept 2024
- Expected to end
- 30 Sept 2027
- Type of study
- Interventional
- Record updated
- 13 November 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 18 to 64 to test the safety and tolerability of COR-1389 and how the body handles it. The record lists healthy participants.
- Age
- 18 to 64 years
- Sex
- All sexes can join.
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 64 years old?
Where in Germany
- PROFIL Institut fuer Stoffwechselforschung GmbHNeuss, GermanyTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorData and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).
- Plain-language title
- Tests COR-1389 safety in healthy adults aged 18 to 64Generated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Fit questions
- Built from 2024-514853-31-00, who can take part
- Record updated
- 13 November 2026